Norges Bank Atara Biotherapeutics, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

46 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2024
BUY
$1.41 - $2.31 $854,892 - $1.4 Million
606,307 New
606,307 $897,000
Q3 2023

Nov 13, 2023
SELL
$1.41 - $2.31 $1.13 Million - $1.85 Million
-799,758 Closed
0 $0
Q2 2023

Aug 14, 2024
BUY
$1.5 - $3.04 $1.05 Million - $2.12 Million
698,507 New
698,507 $1.12 Million
Q2 2023

Aug 14, 2023
SELL
$1.5 - $3.04 $1.2 Million - $2.43 Million
-799,758 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$2.8 - $5.46 $3.41 Million - $6.64 Million
1,216,213 New
1,216,213 $3.53 Million
Q4 2022

Feb 14, 2023
BUY
$2.85 - $5.18 $2.48 Million - $4.5 Million
868,658 New
868,658 $2.85 Million
Q3 2022

Nov 13, 2023
BUY
$2.85 - $8.73 $2.28 Million - $6.98 Million
799,758 New
799,758 $3.02 Million
Q2 2022

Aug 14, 2023
BUY
$4.69 - $9.84 $3.75 Million - $7.87 Million
799,758 New
799,758 $6.23 Million
Q1 2022

May 12, 2023
BUY
$8.44 - $16.89 $904,768 - $1.81 Million
107,200 Added 12.34%
975,858 $9.07 Million
Q1 2022

May 09, 2022
SELL
$8.44 - $16.89 $8.24 Million - $16.5 Million
-975,858 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$14.7 - $19.89 $14.3 Million - $19.4 Million
975,858 New
975,858 $15.4 Million
Q3 2021

Nov 14, 2022
BUY
$11.99 - $17.9 $9 Million - $13.4 Million
750,614 New
750,614 $13.4 Million
Q3 2021

Nov 05, 2021
SELL
$11.99 - $17.9 $9.27 Million - $13.8 Million
-773,147 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$12.89 - $16.58 $9.97 Million - $12.8 Million
773,147 New
773,147 $12 Million
Q2 2021

Aug 10, 2021
SELL
$12.89 - $16.58 $10.6 Million - $13.7 Million
-824,362 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$14.0 - $20.72 $11.5 Million - $17.1 Million
824,362 New
824,362 $11.8 Million
Q1 2021

May 07, 2021
SELL
$14.0 - $20.72 $19 Million - $28.1 Million
-1,357,222 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$12.67 - $26.23 $17.2 Million - $35.6 Million
1,357,222 New
1,357,222 $26.6 Million
Q4 2020

Feb 10, 2021
SELL
$12.67 - $26.23 $27.4 Million - $56.6 Million
-2,158,846 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$11.92 - $15.87 $25.7 Million - $34.3 Million
2,158,846 New
2,158,846 $28 Million
Q3 2020

Nov 10, 2020
SELL
$11.92 - $15.87 $21.6 Million - $28.8 Million
-1,815,828 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$7.53 - $14.93 $13.7 Million - $27.1 Million
1,815,828 New
1,815,828 $26.5 Million
Q2 2020

Aug 07, 2020
SELL
$7.53 - $14.93 $7.56 Million - $15 Million
-1,003,746 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$5.69 - $17.78 $5.71 Million - $17.8 Million
1,003,746 New
1,003,746 $8.54 Million
Q1 2020

May 08, 2020
SELL
$5.69 - $17.78 $5.71 Million - $17.8 Million
-1,003,746 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$10.89 - $16.79 $10.9 Million - $16.9 Million
1,003,746 New
1,003,746 $16.5 Million
Q4 2019

Feb 12, 2020
SELL
$10.89 - $16.79 $10.9 Million - $16.9 Million
-1,003,746 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$12.03 - $19.94 $12.1 Million - $20 Million
1,003,746 New
1,003,746 $14.2 Million
Q3 2019

Nov 08, 2019
SELL
$12.03 - $19.94 $11.5 Million - $19.1 Million
-958,746 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$19.05 - $41.04 $18.3 Million - $39.3 Million
958,746 New
958,746 $19.3 Million
Q2 2019

Aug 09, 2019
SELL
$19.05 - $41.04 $11.3 Million - $24.4 Million
-594,345 Closed
0 $0
Q4 2018

Mar 04, 2019
BUY
$30.9 - $42.97 $18.4 Million - $25.5 Million
594,345 New
594,345 $20.6 Million
Q4 2018

Feb 08, 2019
SELL
$30.9 - $42.97 $14.2 Million - $19.8 Million
-461,093 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$35.05 - $43.5 $16.2 Million - $20.1 Million
461,093 New
461,093 $19.1 Million
Q3 2018

Nov 09, 2018
SELL
$35.05 - $43.5 $7.45 Million - $9.25 Million
-212,540 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$35.15 - $51.45 $7.47 Million - $10.9 Million
212,540 New
212,540 $7.81 Million
Q2 2018

Jul 23, 2018
SELL
$35.15 - $51.45 $7.47 Million - $10.9 Million
-212,540 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$18.0 - $48.35 $3.83 Million - $10.3 Million
212,540 New
212,540 $8.29 Million
Q1 2018

May 09, 2018
SELL
$18.0 - $48.35 $6.25 Million - $16.8 Million
-347,442 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$13.2 - $18.1 $4.59 Million - $6.29 Million
347,442 New
347,442 $6.29 Million
Q4 2017

Feb 09, 2018
SELL
$13.2 - $18.1 $5.27 Million - $7.22 Million
-399,155 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$13.25 - $17.05 $5.29 Million - $6.81 Million
399,155 New
399,155 $6.61 Million
Q3 2017

Nov 07, 2017
SELL
$13.25 - $17.05 $5.29 Million - $6.81 Million
-399,155 Closed
0 $0
Q2 2017

Jul 24, 2018
BUY
N/A
115,273 Added 40.61%
399,155 $5.59 Million
Q1 2017

May 11, 2018
BUY
N/A
158,642 Added 126.67%
283,882 $5.83 Million
Q3 2016

Nov 13, 2017
BUY
N/A
125,240
125,240 $0

Others Institutions Holding ATRA

# of Institutions
7
Shares Held
2.89M
Call Options Held
0
Put Options Held
0
View Full List

About Atara Biotherapeutics, Inc.

ATRA Quotes by TradingView
  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $1.25B
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email